Subject Index
Coagulation Factors and Inhibitors
Fibrinolysis, fibrinogen, fibrin
Haemorrhagic Disorders
Invited
Other
Platelets
Thrombotic Disorders and antithrombotic therapy
Vascular Biology
Thrombotic Disorders and antithrombotic therapy
Animal and experimental models
Antiphospholipid antibodies
Cancer and thrombosis
Cerebrovascular disease
Clinical trials: antiplatelet agents
Clinical trials: direct antithrombin agents
Clinical trials: fibrinolytic therapy
Clinical trials: heparins/LMWH
Clinical trials: oral anticoagulants
Diabetes and metabolic disorders
DVT and pulmonary embolism
Familial thrombosis
Gene therapy
Genetic determinants and epidemiology
Homocysteine
Hormone, pregnancy
Hypercoagulability
Inflammation, infection and immunity
Ischaemic heart disease
New antithrombotic agents and approaches
New intravascular devices
Other thrombotic disorders and antithrombotic therapy
Polymorphism and arterial disease
TTP and HUS
A functional single-nucleotide polymorphism in the thrombin-activatable fibrinolysis inhibitor (TAFI) associated with risk and outcome of meningococcal disease (MD)
Kremer Hovinga J., Franco R. F., Zago M. A., Ten Cate H., Westendorp R. G., Reitsma P. H.
A single point mutation of asparagine 511 to serine is responsible for the increased rate of cleavage of high molecular weight in Lewis rat, which is genetically susceptible to inflammatory stimuli
Pixley R., Isordia-Salas I., Parekh H., Li F., Sartor R. B., Colman R. W.
Acquired protein S deficiency in HIV-infected patients is corrected under HAART
Toulon P., Bachmeyer C., Metge S.
Alterations in lipoprotein homeostasis during experimental and clinical sepsis in primates
Levels J. H. M., Pajkrt D., Schultz M., Van Den Ende A. E., Hoek F. J., Van Tol A., Taylor F. B., Hack C. E., Meijers J. C., Van Deventer S. J.
Anti-inflammatory mechanisms of PS3, a new drug candidate with both anti-inflammatory and anti-thrombotic activities
Alban S., Becker M., Franz G.
Anti-protein Z antibodies in women with abnormal pregnancies
Gris J. C., Amadio C., Mercier E., Lavigne G., Déchaud H., Hoffet M., Quéré I., Amiral J., Dauzat M., Marès P.
Blood-borne tissue factor aggravates the outcome of endotoxemia
Schoenmakers S. H. H. F., Groot A. P., Florguin S., Reitsma P. H., Spek C. A.
Circulating prostaglandin E2 is associated with high risk of coronary heart disease in asymptomatic subjects: a novel inflammatory marker of subclinical atherosclerosis
Páramo J. A., Beloqui O., Orbe J., Monasterio A., Coma I., Colina I., Díez J.
Coagulation and complement inhibitors levels predict outcome in patients with severe sepsis
Siragusa S., Lo Coco L., Schiralli F., Riina F., Minardi V., Malato A., Raineri S. M., Giarratano A., D'Angelo U., Donzelli M., Federico A.
Coagulation and endothelium activation in patients with scrub typhus
Toulon P., Dumont B., Burnouf T., Watt G. H.
Coagulation inhibitor monitoring rationale in critical patients with severe sepsis
Isvarlal P., Marinho A., Pereira I., Polo S., Lau C., Moura P., Pinho N., Matos E., Brandão M., Campos M., Justiça B.
Complement C3 and its relationship to features of the insulin resistance syndrome and cardiovascular disease
Carter A. M., Futers T. S., Ajjan R., Brown J. M., Grant P. J.
C-reactive protein and the 10-year incidence of coronary heart disease in older men and women: the Cardiovascular Health Study (CHS)
Cushman M., Arnold A. M., Manolio T. A., Psaty B. M., Kuller L. H., Polak J. F., Burke G. L., Tracy R. P.
C-reactive protein induces the expression of tissue factor and interleukin-8 in the lung
Gabazza E. C., Nakano M., Ohta K., Hayashi T., Kamada H., Taguchi O., Adachi Y., Suzuki K.
C-reactive protein: a link between inflammation and thrombosis formation in patients with unstable angina?
El Ali M., Teodoridis T., Karabinos I., Koulouris S., Krandis A., Lekatsas J., Exadaktylos N., Cokkinou V.
Different pattern of hemostatic abnormalities in infectious and noninfectious systemic inflammatory response syndrome (SIRS)
Malyszko J., Czaban S., Krajewski J., Wolczynski S., Malyszko J., Siemiatkowski A., Mysliwiec M.
Dynamics of changes of parameters of a hemostasis in patients with sepsis
Rudakova V. E., Sergeeva E. V., Vasiljev S. A., Berkovsky A. L., Orel E. B., Gavrilova A. V., Avdonin P. V., Galtsjan G. M., Gorodetsky V. M.
Dynamics of changes of parameters of a hemostasis in patients with sepsis
Berkovskiy A. L., Rudakov V. E., Sergeeva E. V., Vasilyev S. A., Gavrilova E. B., Avdonin P. V., Galstyan G. M., Gorodestskiy V. M.
Evidence for a serum protein mediating Staphylococcus aureus induced platelet aggregation
Brennan M., Foster T. J., Cox D.
HLA-DR and CD40 ligand expressing T-lymphocytes are increased in circulation in patients with idiopathic dilated cardiomyopathy
Ueno A., Murasaki K., Kawana M., Tanoue K., Kasanuki H.
Hyperhomocysteinemia and other thrombophilic factors in Italian patients with inflammatory bowel disease
Silingardi M., Beltrami M., Fornaciari G., Iorio A., Ghirarduzzi A., D'Incà M., Negri E., Casali A., Morini L., Iori I.
Is inflammation involved in the development of thrombosis in patients with the lupus anticoagulant?
Sailer T., Vukovich T., Lehr S., Koder S., Quehenberger P., Panzer S., Lechner K., Pabinger I., Zoghlami-Rintelen C.
Neutrophils rapidly recruited by TNF-a stimulated endothelial cells can exit the sub endothelial environment by reverse transmigration over hours: is this a novel route for neutrophil clearance from inflamed tissue?
Stone P. C. W., Mcgettrick H. M., Nash G. B., Rainger G. E.
New functions of neutrophils in inflammation: tissue factor-triggered clotting induction and elastase-mediated fibrinolysis
Imamura T., Nakamura S.
Oxidized phospholipids inhibit action of endotoxin in vitro and in vivo
Bochkov V. N., Gruber F., Binder B. R., Leitinger N.
Postpartum bone mineral density in women treated for thromboprophylaxis with unfractionated heparin or LMW heparin
Kaaja R., Pettilä V.
Prediction of the organ dysfunctions by coagulation/fibrinolysis molecular markers at the beginning of sepsis
Iba T., Kidokoro A., Fukunaga M., Sugiyama K.
Randomized trial of tinzaparin, a low molecular weight heparin (LMWH) vs. placebo in the treatment of mild-to-moderately active ulcerative colitis
Lassen M., Bloom S., Kiilerich S., O'Morain C., Forbes A., Orm S.
Suppression of thrombin generation and fibrinolysis in patients with rheumatoid arthritis treated with anti-TNFa monoclonal antibody (Infliximab)
Gluszko P., Lowenhoff T., Undas A., Kwasny-Krochin B., Skura A., Iwaniec T.
The role of herpetic infections in genesis of endothelial damage in pregnant women with fetal loss syndrome
Dolgushina N., Makatsaria A. D.
Variation in plasminogen activator inhibitor-1 gene and risk of meningococcal disease
Geishofer G., Zenz W., Moritz M., Müller W., Walcher W., Endler G., Häring D., Faber J., Finn A., Mannhalter CH.